ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 103 filers reported holding ANTARES PHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $53,000 | +26.2% | 16,613 | +12.2% | 0.02% | +50.0% |
| Q1 2017 | $42,000 | -32.3% | 14,800 | -44.2% | 0.01% | -17.6% |
| Q4 2016 | $62,000 | -60.3% | 26,516 | -71.4% | 0.02% | -54.1% |
| Q3 2016 | $156,000 | +642.9% | 92,599 | +424.9% | 0.04% | +1750.0% |
| Q4 2015 | $21,000 | -91.1% | 17,642 | -87.4% | 0.00% | -91.3% |
| Q3 2015 | $237,000 | -0.4% | 139,642 | +22.0% | 0.02% | 0.0% |
| Q2 2015 | $238,000 | -12.5% | 114,430 | +13.9% | 0.02% | -14.8% |
| Q1 2015 | $272,000 | -14.2% | 100,453 | -18.6% | 0.03% | -10.0% |
| Q4 2014 | $317,000 | +6.0% | 123,418 | -24.5% | 0.03% | +15.4% |
| Q3 2014 | $299,000 | +149.2% | 163,407 | +264.0% | 0.03% | +188.9% |
| Q2 2014 | $120,000 | – | 44,886 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |